Near-Infrared Therapy

Near-infrared (NIR) therapy delivers invisible light in the 700-1100nm wavelength range to penetrate deep into the body's tissues, reaching muscles, joints, bones, and even neural tissue at depths that visible red light cannot achieve. The 700-1100nm range is known as the 'optical window' or 'therapeutic window' because it coincides with the minimum absorption of hemoglobin, water, and melanin, allowing photons to travel several centimeters into tissue with minimal scattering. Within this range, the most clinically validated wavelengths are 810nm, 830nm, and 850nm, which are absorbed by cytochrome c oxidase and other cellular chromophores to stimulate mitochondrial energy production, modulate inflammation, and promote tissue repair at depth. A 2024 review published in Frontiers in Neurology (Henderson & Morries) examined the physics of infrared light penetration in human tissue and confirmed that NIR wavelengths between 700-900nm achieve the deepest tissue penetration due to reduced absorption by biomolecules in this spectral window, with photon penetration reaching several millimeters to centimeters depending on tissue type, wavelength, and power density. This deep penetration capability makes NIR therapy particularly valuable for conditions affecting deep structures. A controlled trial published in Photomedicine and Laser Surgery demonstrated that combined red and near-infrared treatment (570-850nm) produced significant improvements in intradermal collagen density at depths beyond what red light alone could reach. For neurological applications, transcranial near-infrared therapy at 810nm has shown promising results in preliminary studies for traumatic brain injury (TBI) and cognitive enhancement, though larger trials are still needed. In musculoskeletal medicine, NIR at 830nm and 850nm has been studied extensively for knee osteoarthritis, tendinopathies, and low back pain, with multiple systematic reviews finding moderate evidence for short-term pain reduction. NIR therapy is delivered via laser diodes, high-power LED panels, or combination red/NIR devices. Because near-infrared light is invisible to the human eye, devices typically include visible red indicator lights so users can confirm the device is active. Sessions last 10-20 minutes per treatment area, and protective eyewear should be worn when treating near the face. NIR therapy is often combined with visible red light (620-700nm) in dual-wavelength devices to provide both superficial (skin, dermis) and deep tissue (muscle, joint, bone) benefits simultaneously. This combination approach has become the standard in most commercial red light therapy panels and beds, making pure NIR-only treatments less common in consumer settings but still preferred in clinical protocols targeting deep tissue pathology.